Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 71-80 of 2856 for cancer

Edit search filters
  1. Ulixertinib In People With Histiocytic Neoplasms

    Rochester, MN

  2. A Phase Ⅲ Study Of Rilvegostomig In Combination With Fluoropyrimidine And Trastuzumab Deruxtecan As The First-line Treatment For HER2-positive Gastric Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  3. A Study To Evaluate A Resilient Living Program For Patients With Advancer Cancer And Their Caregivers

    Rochester, MN

  4. A Phase 1 Study Of XL309 (ISM3091) Alone And In Combination In Patients With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Phase 1/2a Study Of IMM-1-104 In Participants With Previously Treated, RAS-Mutant, Advanced Or Metastatic Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. ADG126 In Combination With Pembrolizumab In Patients With Advanced/Metastatic Solid Tumors

    Jacksonville, FL, Rochester, MN

  7. A First-in-Human Study Of MEN2312 In Adults With Advanced Breast Cancer

    Rochester, MN

  8. A Study To Compare Mobile Health And Social Media Physical Activity Intervention Among Adolescent And Young Adult Childhood Cancer Survivors

    Rochester, MN

  9. Testing The Addition Of An Anti-Cancer Drug, Gemcitabine, To Usual Treatment (BCG Alone) In People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Clinical Study To Test If An Investigational Treatment Called BNT326 Is Safe And Potentially Beneficial When Used Alone Or In Combination With Other Investigational Treatments Such As BNT327, For People With Advanced Malignant Tumors

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer